Tap Water Contaminants — Body Handbook

Water · §383

Tap Water Contaminants

The water at your kitchen tap meets federal limits. That is not the same as clean. Roughly half of US taps carry detectable PFAS — synthetic "forever chemicals" linked to kidney and testicular cancer. Around 9.2 million lead service lines still feed American homes, leaching at a rate with no known safe threshold. And the chlorine that ended waterborne cholera reacts with organic matter on the way to your house, forming the disinfection byproducts behind two decades of bladder-cancer signal. None of it is acute; all of it is removable with a filter certified to the right standard.

Do · As-needed Evidence Moderate Chapter Water

The win is real but slow: a certified household filter removes a class of involuntary, decade-accumulating exposures whose effect on any single reader's lifespan is small and whose effect on national mortality is large. The catch is that "federally compliant" was set to what utilities could afford to clean, not what's actually safe — chasing the legal limit undersells what's available with a $30–80 pitcher on the right standard. None of the three big contaminant families will make you feel anything tomorrow; that's also why the default is to ignore them.

Three contaminant families do almost all the chronic-disease work. PFAS are built on carbon-fluorine bonds, the strongest in organic chemistry — which is why they neither break down in nature nor metabolize cleanly out of the body. They sit in blood for two to five years ATSDR 2021, bind serum proteins, disrupt fat metabolism, suppress the antibody response to vaccines, and interfere with thyroid hormone signalling DeWitt et al. 2012.

Lead enters the water from the service line that connects the street main to your house, from lead solder used in copper joints up to 1986, and from brass fixtures. Corrosive water — low pH, low alkalinity, the wrong chemistry — peels lead off the pipe wall. Once swallowed, lead substitutes for calcium in bone, where it sits for decades, then crosses into the brain and interferes with the same calcium-dependent signalling neurons use to fire. There is no known threshold of safe exposure; the IQ cost per microgram of blood lead is larger at low doses than at high ones Lanphear et al. 2005.

Disinfection byproducts form after the water leaves the treatment plant. Chlorine — the public-health miracle that ended waterborne cholera and typhoid — reacts with natural organic matter (humic acids from leaves, soil, runoff) and with bromide in the source water to form trihalomethanes and haloacetic acids. Two routes of absorption matter: drinking the water, and bathing in it. Hot showers volatilize the chemicals into the air you breathe; warm water opens your skin to dermal uptake Villanueva et al. 2007.

How sure we are, and how big

Three independent bodies of human data converge — each replicated, each with a different mechanism, each pointing at a different chronic disease endpoint. That's the case for taking this seriously even without a randomized trial of household filters (there isn't one, and at decade timescales there probably never will be).

PFAS. The C8 Health Project enrolled about 69,000 mid-Ohio-valley residents who'd been drinking water downstream of DuPont's Washington Works plant. Its Science Panel concluded there was a "probable link" between PFOA and six conditions: kidney cancer, testicular cancer, ulcerative colitis, thyroid disease, pregnancy-induced hypertension, and high cholesterol Steenland et al. 2020. The kidney-cancer hazard ratio in the highest exposure quartile came in around 1.35 Barry et al. 2013. A separate child cohort showed that doubling serum PFOS at age 5 cut the diphtheria antibody titer after booster vaccination in half — the immunotoxicity finding cited by both the EPA and the National Academies Grandjean et al. 2012.

Lead. The cleanest population data come from Lanphear et al. 2018, a 14-year follow-up of NHANES-III: the dose-response curve for blood lead and cardiovascular mortality extends down to about 1 microgram per deciliter, with no inflection point at any "safe" threshold. The attributable-fraction math is what makes lead the dominant chronic exposure in this entry.

Disinfection byproducts. Beyond the Villanueva and Costet bladder-cancer signals already covered above, a broader review of the disinfection-byproduct evidence — Hrudey 2009 — concluded the bladder-cancer association is the strongest specific endpoint, while flagging adverse-pregnancy outcomes (low birthweight, small-for-gestational-age) as a weaker and less consistent signal. The population-attributable-fraction estimates for bladder cancer at typical European concentrations run 5% to 18% of cases.

Other contaminants worth knowing about. Nitrate from agricultural runoff causes methemoglobinemia in infants above 10 milligrams per liter, the federal limit, and shows emerging cohort signals for colorectal cancer and thyroid disease at chronic exposures below the limit Ward et al. 2018. Arsenic, hexavalent chromium, and a growing list of pharmaceutical residues are real concerns in specific watersheds and are covered by the same filtration technology described below.

What keeps happening if you don't

The harm doesn't broadcast. There's no week where you wake up worse because of last Tuesday's PFAS. Nobody is going to look at you across a table and say "you've been drinking unfiltered tap water, haven't you." That is the failure mode of this whole class of exposure: the body absorbs the chemicals, the chemicals do exactly what the mechanism says, and the felt experience reports back nothing.

What does happen, slowly, is that PFOS and PFOA accumulate in your serum at parts-per-billion concentrations and stay there for years; lead deposits in bone where it sits for decades and slowly leaches back into circulation; bladder epithelium accumulates the integrated dose of disinfection byproducts every time you drink, shower, and bathe. The exposure that arrives at your house this Tuesday is a smaller version of the exposure that already arrived twenty Tuesdays ago, and the year ten reading on your blood tells the story.

The version of your fifties that quietly avoids a kidney-cancer scare is the one that has been drinking filtered water for twenty years. The version that doesn't get the bladder-cancer letter at 62 already replaced its showerhead carbon filter. The version of your parents' generation that didn't lose IQ to childhood lead is the one that grew up after lead paint and lead pipes were phased out — and a measurable share of the cardiovascular mortality in their cohort traces back to the lead that did get in Lanphear et al. 2018. None of these futures arrives loudly. They are subtractions from a base rate, not deliveries to your doorstep.

And the closer to the source of unfiltered exposure you live — older city, lead service line still in the ground, military base or industrial facility in the watershed — the more the subtraction is worth.

What to actually do

Three steps, in order. The middle one is where most people pick the wrong product; the first one is where most people skip a free piece of information.

1. Find out what's actually in your tap. Every community water system serving more than 25 people is required to publish a Consumer Confidence Report (CCR) by July 1 every year — usually mailed with the bill or posted on the utility's website. It tells you which contaminants are present, at what concentration, against the federal limit. Cross-reference your ZIP code in the EWG Tap Water Database, which scores the same data against health-based reference concentrations (stricter than federal). For lead and PFAS specifically, the CCR understates household exposure, because both arrive downstream of the utility's compliance sampling — lead from your service line and plumbing, PFAS that the system isn't yet required to test for. If you live in pre-1986 housing or a city with a lead-service-line replacement program, a $30–50 home test kit using the EPA's first-draw protocol (a 1-liter sample after 6+ hours of water sitting in the pipes) gives the only number that matters.

2. Match the filter to the contaminants. Filters carry NSF certifications; the certification number tells you what the filter is rated to remove.

NSF 42 — taste, odor, chlorine. Not health protection. Most cheap pitchers stop here.
NSF 53 — health contaminants including lead, mercury, and most disinfection byproducts.
NSF P473 — PFOA and PFOS specifically.
NSF 401 — pharmaceuticals and "emerging compounds".
NSF 58 — reverse osmosis systems; covers nearly everything in one technology.

The right baseline for a city-water household is a unit certified to 53 + P473, ideally also 401. A pitcher or faucet-mount at this certification level costs about $30 to $80 up front. Under-sink carbon-block systems are $150 to $300. Point-of-use reverse-osmosis (the most thorough single technology, removing 95%+ of PFAS, lead, nitrate, arsenic, and chromium) is $200 to $500 up front and produces 2 to 4 gallons of reject water per gallon of drinking water.

3. Replace cartridges on schedule. Carbon-block cartridges saturate after about 6 months or 600 gallons. Reverse-osmosis membranes last 2 to 3 years; sediment pre-filters every 6 to 12 months. A spent cartridge is not a neutral object — it's a concentrated reservoir of the contaminants it captured.

What most guides get wrong

"Bottled water is cleaner." The FDA regulates bottled water under standards that mirror, and in places trail, the EPA's primary drinking water regulations. Roughly a quarter of US bottled water is municipal tap, sometimes with extra filtration. Plastic-bottle samples carry measurable PFAS, microplastics, and antimony leached from PET. Bottled water also costs about a thousand times what filtered tap does per gallon. Default to filtered tap; reserve bottled for travel.

"Chlorine is the problem." Chlorine at the residual concentrations utilities maintain (a fraction of a milligram per liter at the tap) is the reason American children don't die of cholera or typhoid the way they did in 1900. The disinfection byproducts chlorine generates after it leaves the plant are the trade-off — and the only honest framing is that the trade is worth taking and then filtering downstream. Removing chlorine residual upstream of the household would kill more people than the disinfection byproducts will.

"If the utility says it's compliant, it's safe." Federal Maximum Contaminant Levels were set decades ago at the concentration utilities could afford to treat to — not at the concentration that's biologically safe. The EPA's own non-enforceable goal for both PFOA and lead is zero; the goal it can actually require utilities to hit is what got written into the rule EPA 2024 PFAS NPDWR. A compliant utility is the floor, not the ceiling.

"Boiling cleans it." Boiling kills bacteria — useful in a boil-water advisory. It does not remove lead, PFAS, nitrate, or disinfection byproducts. Boiling actually concentrates them by evaporating water mass.

"My filter is a filter." A pitcher certified only to NSF 42 (taste and odor) does not remove lead, PFAS, or most disinfection byproducts. The cheaper pitcher next to the certified one on the shelf can look identical and protect against nothing in this article. The number on the back of the box is the only thing that distinguishes them.

The real-world money and friction

Annual cost ranges, US 2024 dollars:

Pitcher or faucet-mount (NSF 53 + P473): $30–80 up front, $50–150 a year in cartridges. Good for one or two people, kitchen-sink-only protection. The cheapest meaningful intervention.
Under-sink dual-stage carbon block: $150–300 up front, $80–200 a year. Better flow rate, longer cartridge life, dedicated faucet.
Point-of-use reverse osmosis: $200–500 up front, $80–150 a year. The most thorough single technology; wastes 2 to 4 gallons of reject water per gallon produced; demineralizes the water (most systems offer a remineralization cartridge for the finished product).
Whole-house: $500–2,500 up front. Worth it if you're optimizing for the dermal-and-inhaled disinfection-byproduct dose from showers; overkill if you only care about ingestion.

Where to find your CCR: search the EPA's Safe Drinking Water Information System (SDWIS) by ZIP code, or your utility's website. For PFAS specifically, the EPA's UCMR 5 monitoring program (2023–2025) gives a more complete national picture than older CCRs that predated PFAS testing requirements.

If you want a number that reflects what arrives at your tap rather than the utility's average, a state-certified-lab home test runs $150–500 for a comprehensive panel: lead, PFAS by EPA Method 537.1 or 533, disinfection byproducts, nitrate. Some state programs and lead-service-line replacement projects offer free PFAS or lead testing — worth checking before paying for one.

Renting versus owning matters less than people assume. A pitcher and a faucet-mount filter both travel; an under-sink and a reverse-osmosis system come out with you on a moving day with a wrench.

What changes once you do it

Be honest with yourself: not much, in week one. The chlorine taste and smell drop out of the glass. The tea brews a little cleaner. That is most of what you'll notice in the first month, and it's not what this entry is selling.

By six months the cartridge is past its prime and you're either swapping it on schedule — meaning the system is still doing what you bought it for — or you've slid into the failure mode where the saturated filter starts releasing what it captured. The infrastructure of the routine is what makes the rest of the payoff arrive: you replaced the cartridge in March and again in September; nobody noticed; the household keeps drinking from the certified tap.

Over the first year your blood concentration of PFOS and PFOA begins to drop. The decline is slow — the half-life of these compounds in human serum is two to five years ATSDR 2021 — but it starts the day the inflow stops. Lead body burden also begins falling, more slowly still, dominated by the bone reservoir's release rate.

Over a decade the integrated dose of all three contaminant families is reduced by 80% to 99% depending on which filter you picked, and your contribution to your own contaminant-attributable risk profile shrinks by a similar fraction. None of this is felt; all of it is real. The version of you at sixty-five with a cleaner kidney-cancer hazard, a lower cardiovascular-attributable-fraction from lifetime lead, and a bladder that hasn't been integrating disinfection byproducts twice a day for thirty years — that version doesn't know it dodged anything. It just goes to fewer specialist appointments than the version that didn't filter.

For the household with a kid in it, the payoff lands earlier. The pediatric IQ deficit from low-level blood lead Lanphear et al. 2005 is the closest thing in this entry to a near-term consequence — not in months but across the years when developing brains are still scaling. Filtering at the kitchen tap takes one of the two main childhood lead routes (the other is paint dust) and closes it.

Adjacent topics worth a look

Fluoride. Added intentionally for dental benefit; the cost-benefit and the neurotoxicity-at-typical-doses debate are their own argument and warrant their own entry.
Private well water. Entirely unregulated. Contaminant profile depends on local geology and surrounding land use. If your water doesn't come from a municipal system, the testing protocol and filter choices in this entry don't apply cleanly.
Microplastics and nanoplastics in drinking water. Detectable in most US taps and most bottled water; human epidemiology is essentially zero. Reverse osmosis removes them; the harm story is not yet pinned down.
Water hardness, alkalinity, and dietary mineral intake. Reverse-osmosis water is demineralized; over the long run this is a small but non-zero subtraction from dietary calcium and magnesium. Easy to offset with diet or a remineralization cartridge.
Hydration itself. How much water to drink is a separate question from what's in it.

Related in the handbook

— Tap water can carry Acanthamoeba; that's why rinsing or storing contact lenses in it risks a sight-threatening eye infection.
— Chlorine byproducts don't only come from drinking — a hot shower gasses them off too, which is the case for a shower filter.
— Knowing the contaminants in your supply is the input that decides which filter type you need.
— The reverse-osmosis filter that strips PFAS and lead also strips beneficial minerals — which is why remineralizing follows.
— If your tap water isn't reliably safe, storing it in copper overnight kills many of the bacteria.
— Tap water is fine to drink but not to pour up your nose; a rare amoeba makes saline rinses one place tap water can actually kill you.
— PFAS show up in some tap water as well as non-stick pans; both are worth checking when you're reducing forever-chemical exposure.
— The water you sip all day is the same water carrying these contaminants. The more you drink, the more a certified filter pays off.
— Same defensive move as buying organic for the high-spray dozen — clean up the inputs you can, skip the panic.
— Bottled water trades tap contaminants for microplastics — a filtered tap and a steel bottle dodges both.
— Fluoride is added on purpose, unlike the contaminants here — but both are reasons to actually know what your tap carries.

Substance and claimed effects

The "substance" here is the chemistry inside the tap a reader drinks from every day — specifically the three contaminant families that drive most of the chronic-disease burden in modern US municipal water: per- and polyfluoroalkyl substances (PFAS), lead (Pb) leached from service lines and household plumbing, and disinfection byproducts (DBPs) — primarily trihalomethanes (THMs) and haloacetic acids (HAAs) — formed when the chlorine the utility adds to kill pathogens reacts with natural organic matter in the source water. Secondary contaminants of interest: nitrate from agricultural runoff, hexavalent chromium, arsenic. The entry covers (a) what each contaminant does inside the body (mechanism), (b) the chronic-disease endpoints with the strongest epidemiology — kidney and testicular cancer, bladder cancer, cardiovascular mortality, IQ deficits, immune suppression, low birthweight, thyroid disease — (c) how to find out what's in your specific tap (the utility-issued Consumer Confidence Report; the EWG Tap Water Database EWG Tap Water Database; private testing), and (d) the household intervention — filtration certified to NSF/ANSI 53, 58, and 401/P473 — that actually removes them at the point of use.

Evidence by addressing question

mechanism

PFAS are a family of ~15,000 synthetic fluorinated chemicals built around carbon-fluorine bonds — among the strongest in organic chemistry, which is why they neither break down in the environment ("forever chemicals") nor metabolize cleanly in the body. PFOA and PFOS, the two most-studied, have human serum half-lives of roughly 2 to 5 years ATSDR 2021. They bind serum albumin and accumulate in liver, kidney, and serum. Mechanistically they are PPAR-alpha agonists, disrupt lipid metabolism, suppress antibody response to vaccines via T-cell-dependent pathways DeWitt et al. 2012, and interfere with thyroid hormone transport. Smalling et al. 2023, a USGS national sampling, detected at least one PFAS in ~45% of US tap-water samples — public-supply and private-well combined — with urban-source water carrying a higher PFOA/PFOS load.

Lead in tap water comes almost exclusively from premise plumbing: lead service lines (estimated 9.2 million still in service in the US per EPA's 2024 LCRI), lead solder used through 1986, brass fixtures, and galvanized iron downstream of lead. Corrosive water (low pH, low alkalinity, or chloride-to-sulfate mass ratio above ~0.5) leaches lead from the pipe wall. Once ingested, lead substitutes for calcium in bone (half-life ~25 years), crosses the blood-brain barrier, and interferes with calcium-dependent neurotransmission, heme synthesis (via ALAD inhibition), and vascular endothelial nitric oxide signaling. There is no known threshold of safe exposure — dose-response curves are supralinear at low doses, meaning the marginal IQ point loss per µg/dL of blood lead is larger below 10 µg/dL than above it Lanphear et al. 2005.

Disinfection byproducts form when chlorine (or chloramine) reacts with natural organic matter — humic and fulvic acids — and bromide in source water. THM4 (chloroform, bromodichloromethane, dibromochloromethane, bromoform) and the regulated five HAAs are the bulk of the mass; hundreds of other DBPs (NDMA, iodoacetic acids, MX) are present at lower concentrations but higher per-molecule toxicity. Animal data show liver, kidney, and bladder carcinogenicity for several DBPs; the proposed human mechanism for bladder cancer is metabolic activation by glutathione-S-transferase theta 1 (GSTT1), which concentrates reactive intermediates in transitional bladder epithelium Hrudey 2009. Exposure is not only ingestion: Villanueva et al. 2007 showed that bathing, showering, and swimming-pool exposure contributes substantially to integrated THM dose via dermal absorption and inhalation of volatile species.

evidence

PFAS and chronic disease. The C8 Health Project — a cohort of ~69,000 mid-Ohio-valley residents exposed to PFOA via DuPont's Washington Works plant — produced the bedrock human epidemiology. The C8 Science Panel concluded there was a "probable link" between PFOA and six conditions: kidney cancer, testicular cancer, ulcerative colitis, thyroid disease, pregnancy-induced hypertension, and hypercholesterolemia Steenland et al. 2020. Barry et al. 2013 estimated a hazard ratio of ~1.35 for kidney cancer in the highest quartile of cumulative PFOA exposure. Grandjean et al. 2012 showed that children with doubled serum PFOS at age 5 had ~50% lower diphtheria antibody titers after booster vaccination — a benchmark immunotoxicity finding now cited by the National Academies and the EPA. Frisbee et al. 2010 demonstrated dose-dependent increases in total and LDL cholesterol across the C8 cohort. The EPA's 2024 final Maximum Contaminant Levels — 4 parts per trillion for PFOA and PFOS, with a hazard-index approach for four other PFAS — codified that the health-based concentration is far below historical regulatory limits and pegs current compliance at roughly 6–10% of US public water systems requiring treatment changes EPA 2024.

Lead and mortality. Lanphear et al. 2018, NHANES-III with 14-year mortality follow-up, found that the concentration-response between blood lead and all-cause cardiovascular and ischemic-heart-disease mortality extended down to ~1 µg/dL, with an estimated ~412,000 US deaths per year attributable to historical lead exposure — about 18% of all-cause mortality, dominated by cardiovascular endpoints. The Edwards et al. 2009 Washington DC analysis documented a doubling of elevated blood-lead levels in children during the 2001–2004 chloramine-induced corrosion episode, and Hanna-Attisha et al. 2016 reproduced the pattern in Flint: the proportion of children with blood lead ≥5 µg/dL rose from 2.4% to 4.9% after the water source change. Lanphear et al. 2005, an international pooled analysis of seven cohorts, established the supralinear pediatric dose-response: a roughly 6.9 IQ point deficit going from blood lead 1 to 10 µg/dL, larger than the deficit from 10 to 30 µg/dL.

DBPs and bladder cancer. The bladder-cancer signal is the most consistent of the DBP epidemiology. Villanueva et al. 2007, a Spanish multi-center case-control study, found an odds ratio of ~2.1 for bladder cancer in subjects with long-term average THM exposure above 49 µg/L versus below 8 µg/L, including dermal/inhalation routes. Costet et al. 2011, a European pooled meta-analysis, replicated the association in men (OR ~1.4 at high exposure) but not consistently in women — a sex difference attributable to bathing duration and GSTT1 genotype distribution. Hrudey 2009 reviewed the broader DBP literature and concluded the bladder-cancer link is the strongest specific endpoint, while acknowledging that adverse-pregnancy outcomes (low birthweight, small-for-gestational-age) show weaker and inconsistent associations.

Other contaminants. Ward et al. 2018 summarized the evidence for nitrate: acute methemoglobinemia in infants below 6 months at concentrations above ~10 mg/L NO₃-N (the EPA MCL), and emerging cohort signals for colorectal cancer, thyroid disease, and neural-tube defects at chronic exposures below the MCL. Hexavalent chromium (Cr-VI) is established as a human carcinogen via inhalation; the ingestion pathway is debated but California's OEHHA set a public health goal of 0.02 µg/L (1000-fold below the federal total-chromium MCL). Arsenic remains a problem mostly in private wells and a subset of southwestern US systems.

protocol

The action chain has three stages: (1) find out what's actually in your tap — the utility's annual Consumer Confidence Report (CCR), which every community water system serving >25 people is required to publish by July 1 each year under the Safe Drinking Water Act; cross-reference with EWG's Tap Water Database, which compiles CCR data against health-based (not legal) reference concentrations; for lead and PFAS, the CCR underestimates household exposure because both arrive after the utility's compliance sampling point. (2) Match filtration technology to the contaminant profile. NSF/ANSI 53 certifies removal of specific health-related contaminants; NSF/ANSI 58 covers reverse-osmosis systems; NSF/ANSI 401 covers "emerging compounds" including pharmaceuticals; NSF/ANSI P473 is the dedicated PFAS protocol. Activated carbon block filters certified to 53+P473 remove >90% of regulated PFAS, lead, chlorine, and most DBPs. Reverse osmosis is the most thorough single technology: ~95–99% removal of PFAS, lead, nitrate, arsenic, chromium, and DBPs, at the cost of 2–4 gallons rejected per gallon produced and demineralization that some systems remineralize downstream. (3) Replace cartridges on schedule: carbon-block typically 6 months / 600 gallons; RO membranes 2–3 years; sediment pre-filters every 6–12 months. A spent filter releases accumulated contaminant load back into the effluent, becoming worse than no filter.

contraindications

Filtration itself has no medical contraindications. Two related cautions: (a) Reverse-osmosis water is demineralized; long-term exclusive consumption removes a small but non-zero source of dietary calcium and magnesium. WHO 2022 Guidelines for Drinking-water Quality notes the issue without setting a hard recommendation; clinical relevance is small for adults eating a varied diet but the consensus is that remineralization or balanced dietary intake is preferable to indefinite distilled-grade water. (b) Pitcher and faucet filters that are not certified to NSF 53 (only to NSF 42 for taste/odor) do not remove lead, PFAS, or most DBPs — substituting one for the other gives a false sense of protection. (c) Boiling water concentrates lead, PFAS, and nitrate via evaporative loss of water mass; only deals with microbial contamination, not chemical.

misconceptions

The dominant lay misconception is that bottled water is cleaner than filtered tap. Bottled water is regulated by the FDA under standards essentially mirroring EPA primary drinking water regulations; ~25% of bottled water sold in the US is municipal tap, sometimes with additional filtration. PFAS, microplastics, and antimony leached from PET bottles are present in measurable concentrations. A second misconception: that chlorine itself is the danger. Free chlorine residual at WHO-recommended levels (0.2–0.5 mg/L at point of use) is a public-health triumph that prevents cholera, typhoid, and gastrointestinal disease; the DBPs formed downstream are the trade-off, not the chlorine. A third: that the utility's compliance with the federal MCL means the water is safe. Many federal MCLs predate decades of toxicology and were set at the technology-feasibility level, not the health-based level — the EPA's own non-enforceable Maximum Contaminant Level Goal (MCLG) for PFOA and PFOS is zero EPA 2024; the MCLG for lead is also zero.

practicalities

Cost ladder, US 2024: a certified faucet-mount or pitcher filter (NSF 53 + 401 + P473) runs $30–80 up front with replacement cartridges $50–150/year. A under-sink carbon-block dual-stage runs $150–300 up front, $80–200/year ongoing. A point-of-use reverse-osmosis system runs $200–500 up front, $80–150/year ongoing. Whole-house systems (carbon + sediment + optional RO at kitchen) run $500–2,500 up front; meaningful for PFAS-via-shower exposure but overkill for ingestion alone. Look up the utility's CCR via the EPA's Safe Drinking Water Information System (SDWIS) or the utility's website; for PFAS specifically, the EPA's UCMR 5 monitoring data (2023–2025) gives a more complete picture than older CCRs. Independent testing through a state-certified lab runs $150–500 for a comprehensive panel and is the only way to characterize what arrives at the household tap, downstream of service lines and premise plumbing.

stakes

Aggregated over a lifetime of consumption at typical US concentrations: the lead-attributable cardiovascular mortality fraction from Lanphear et al. 2018 implies a meaningful individual hazard for adults with even modestly elevated chronic blood lead. PFAS body burden takes years of exposure to build and years of clean drinking water to clear (~half-life 2–5 years). DBP-attributable bladder cancer risk scales with cumulative dose; the population-attributable fraction estimates from European data range from 5–18% of bladder cancer cases. None of these is acute. The felt-experience layer — fatigue, cognitive blunting, slow recovery — is real for chronic high lead exposure but not noticeable at typical municipal levels; the harm is statistical and decade-scale.

payoff

Within weeks of installing a certified filter: no felt-experience change for most adults; chlorine taste and odor drop noticeably. Within months: serum PFOS/PFOA concentrations begin to fall on the species' half-life curve; lead body burden also slowly drops (bone reservoir dominates so the curve is slow). Over a decade: integrated cumulative exposure to the three contaminant families is reduced by 80–99% depending on filter choice, translating to a corresponding reduction in the contaminant-attributable fraction of bladder cancer, kidney cancer, and cardiovascular endpoints. Honest framing: the effect on any individual reader's lifetime mortality risk is small in absolute terms (the catalogue's longevity dimension is not "this will add 5 years"); the effect is meaningful at the population level and removes a class of accumulating exposures that the reader has no other way to control.

practicalities — testing the household tap

The CCR is system-level: it samples at the treatment plant and at compliance points within the distribution system. Two contaminants arrive after the compliance sampling: lead from the household service line and premise plumbing, and (sometimes) DBPs that continue forming in the distribution system between compliance points. Home testing kits — usually the same protocols a certified lab would use, sold direct-to-consumer — cost $30–500 depending on panel breadth. For lead, the EPA's recommended protocol is a first-draw 1 L sample taken after 6+ hours of stagnation. For PFAS, EPA Method 537.1 or 533 panels are widely available; many state programs offer free or subsidized PFAS testing for households on lead-service lines.

out-of-scope

Three adjacent topics deliberately not covered as part of this entry: fluoride (added intentionally for dental benefit, separate cost-benefit analysis warrants its own entry, evidence base on neurotoxicity at typical fluoridation levels is contested); private well water (entirely unregulated, contaminant profile is geology-dependent, warrants a separate testing-driven entry); water hardness, fluoridation, and microplastics (each its own evidence base). Also out of scope: hydration itself — how much water to drink — which is upstream of contamination.

The credibility range

The optimist case. Three independent, well-replicated bodies of human epidemiology — C8 for PFAS, NHANES + cohort studies for lead, multi-national case-control series for DBPs — converge on chronic-disease endpoints with plausible mechanisms, dose-response gradients, and large population-attributable fractions. The EPA's 2024 PFAS rule and the simultaneous Lead and Copper Rule Improvements EPA LCRI 2024 represent regulatory consensus that the historical MCLs were too lenient. Filter technology is mature, certified by an independent standards body (NSF), and removes >90% of all three contaminant classes at modest cost. The intervention is cheap, low-effort, and reversible. The skeptic must explain why three independent literatures converge by coincidence.

The skeptic case. The mortality and cancer associations are observational; residual confounding by smoking, socioeconomic status, and co-occurring environmental exposures cannot be ruled out. The Lanphear 2018 attributable-fraction estimate has been contested by analysts who note that the extrapolation to blood lead below 5 µg/dL relies on a small number of NHANES participants. The C8 cohort had unusually high PFOA exposure (median serum ~25 ng/mL vs general population ~3 ng/mL); generalization to the low-exposure majority of municipal water customers is uncertain. The DBP-bladder-cancer association is consistent in men but not in women, and the absolute excess risk at compliant US concentrations is small. No randomized trial of filtration on cancer endpoints exists or is feasible. A motivated skeptic can frame the entry as moving an already-small absolute risk down by a small fraction.

The author's call. The mechanistic plausibility is high, the dose-response is biologically coherent, the regulatory bodies (EPA, WHO, ATSDR) have aligned, and the intervention is cheap. The honest framing: filtration is not a transformative longevity intervention for any single reader, but it is a high-evidence, low-cost removal of a class of involuntary accumulating exposures whose population-level harm is large. Score on the substance, not the article: longevity earns 3–4, evidence earns 4, controversy a modest 2 (PFAS limit values and low-level lead are actively debated; the broad direction is not).

Stakeholder and incentive map

Utilities and municipal governments — incentive to minimize required treatment capex; resistance to MCL tightening on cost grounds. Counter-incentive: legal liability for service-line lead and PFAS, accelerated by Flint and 3M settlements.
Filter manufacturers (Brita, Pur, Aquasana, etc.) — commercial incentive to amplify contamination concerns; certification by NSF provides honest signal but marketing extends beyond certified claims.
Bottled-water industry — commercial incentive to position tap water as unsafe; product is regulated under weaker FDA framework than EPA-regulated tap.
Chemical industry (3M, DuPont/Chemours) — historical incentive to suppress PFAS toxicity data; now exposed through settlements and litigation discovery. The C8 cohort exists because litigation forced disclosure.
Regulatory bodies (EPA, WHO, ATSDR, state DOHs) — political and budget constraints on enforcement timelines. The 2024 PFAS rule comes after two decades of accumulated evidence.
NGOs and watchdogs (EWG, NRDC, Clean Water Action) — incentive to dramatize; the EWG database is well-sourced but its health guidelines are stricter than federal limits.

Population variability

Exposure variability dwarfs response variability for this entry. Source water (PFAS hotspots cluster around military bases, airports, chemical plants, and downstream of wastewater discharge), distribution-system age (lead service lines concentrated in the Northeast, Midwest, and pre-1986 housing stock), and household plumbing (lead solder in copper, brass faucets) collectively span three orders of magnitude in real ingestion. The CCR is geographic; the EWG database resolves to ZIP code; household testing resolves to tap.

Response variability: children and pregnant women have outsized sensitivity to lead (developing CNS), and infants to nitrate (immature methemoglobin reductase). GSTT1 polymorphism modulates DBP carcinogenicity. PFAS clearance is slower in older adults and in men (women clear via menstrual blood). Renal-impaired patients accumulate PFAS faster. Households with private wells, on agricultural land, near landfills, or near industrial sites carry contaminant profiles that the municipal-water framing misses entirely — flagged in the out-of-scope and editor notes.

Knowledge gaps

The largest gap is the absence of randomized intervention trials: no RCT has measured chronic-disease endpoints after household filtration, and given the timescales (decades) and exposure variability, none is likely. Causal inference rests on mechanism + dose-response + cessation studies (e.g., serum PFAS decline after exposure removal). The low-exposure end of the PFAS dose-response — the 1–5 ng/mL serum range where most municipal-water customers sit — has thin epidemiology; the C8 cohort is informative but high-exposure. The cumulative-mixture problem (PFAS + lead + DBPs + other contaminants acting jointly) is acknowledged in regulatory framing (the EPA's hazard-index approach) but not yet quantitatively resolved. New PFAS chemistries — GenX, short-chain replacements — are commercializing faster than their toxicology is being characterized. Microplastics and nanoplastics in tap water are an emerging concern with essentially zero human epidemiology to date.

Coverage relative to brief. The topic description named PFAS, lead, and disinfection byproducts, plus utility reports and home filtration as monitoring/intervention tools. The article covers all three contaminant families end-to-end (mechanism, evidence, protocol, payoff) and treats the CCR + EWG database + state-certified-lab home test as the monitoring layer, certified filtration as the intervention layer. No silent narrowing.

Hard scoping calls.

Fluoride excluded. The intentional-additive case and the neurotoxicity-at-typical-doses debate are a fundamentally different argument from involuntary contaminants. Flagged in out-of-scope as a separate entry.
Private wells excluded. Unregulated, geology-dependent contaminant profile, and the monitoring story (annual testing, no CCR) is materially different. Warrants a separate entry; flagged in out-of-scope.
Microplastics + water hardness + dietary minerals from water all flagged in out-of-scope rather than covered in the body. Microplastics has essentially zero human epidemiology and the others are tangential to the chronic-disease-risk framing.
Nitrate, arsenic, Cr-VI covered briefly in the evidence section but not given full mechanism/protocol treatment — they are watershed-specific and the same filter technology handles them.

Rating difficulties.

Longevity scored 3, not 4. Lead-attributable mortality (Lanphear 2018) is enormous at population scale, but individual risk reduction from removing the tap-water contribution alone — for a typical municipal customer without a lead service line — is modest. A reader in a lead-service-line city near a PFAS hotspot would honestly be at a 4. Averaging the substance across the catalogue's real reader distribution lands at 3. Open to bumping to 4 if editorial consensus is that the population-level case carries more weight.
Evidence scored 4, not 5. Three independent observational literatures with mechanism support; regulatory consensus aligned. The reason it's not 5 is the absence of a randomized trial of household filtration on disease endpoints — and one isn't feasible at decade timescales.
Cadence is awkward. Install is once, cartridge replacement is on a 6-month schedule, CCR check is annual. as-needed captures the lived pattern best (replace cartridge when due, re-check CCR when it lands); daily would overstate effort.
Burden dimensions. Cost burden at 2 assumes a certified pitcher or under-sink; the whole-house option pushes into 3 if the reader prioritises shower disinfection-byproduct dose. Effort burden 1 is for the maintained system; the install step is briefly 2 for an under-sink or RO.

Future-link candidates.

Fluoride in Drinking Water — separate entry.
Private Well Water Testing — separate entry, different category cross-link (likely also home).
Microplastics — own entry when human epidemiology firms up.
Lead Paint Dust — sibling for the childhood-lead pathway; the payoff section names it as the other route.
Showerhead and Whole-House Filtration — the dermal/inhaled DBP route could warrant deeper standalone treatment.

Authorial calls captured in prose. The framing that "federally compliant is the floor, not the ceiling" is the load-bearing editorial position — derived from the EPA's own MCLG-of-zero for PFOA and lead. The stakes section deliberately leans on the social-mirror / subtraction-from-base-rate voice rather than scare statistics, because the harm at typical municipal exposures is genuinely statistical and not felt. If a reviewer wants more punch, the trade is honesty.